Publication Details

Pubmed16697957
Title: NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss.
Year: 2006
DOI: https://doi.org/10.1016/j.ccr.2006.03.031
First Author: Lei
Experimental setup: affinity chromatography technology (Biogrid)
Throughput: Low Throughput (Biogrid)

Interactions

2 interactions
InteractorPartnerSourcesLink
P53_HUMANHDAC1_HUMANBioGRIDdetails
HDAC1_HUMANNKX31_HUMANBioGRIDdetails